Earlier this month, Cievert was selected by Amgen to address a challenge they set out: “Encourage continuity in treatment strategy and treatment optimization for post-myocardial infarction patients”. Penguin was pitched as the ideal solution for monitoring patients...
The EIT have agreed to provide Cievert with significant financial support as they expand into European markets. In addition, they will be hosting Cievert in local accelerators, incubators, and clusters, providing guidance regarding regulatory and market challenges....
Recent Comments